Pneumococcal vaccination in diabetic patients: review from clinical practice
Abstract The Middle East and North Africa (MENA) region has the second-highest rate of increase in diabetes, especially in KSA, Egypt, and UAE. Diabetes accounts for a significant economic burden in terms of the cost of treatment, the management of complications, disability, and the loss of producti...
Main Author: | Amr Ghit |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-02-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43162-023-00202-7 |
Similar Items
-
23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01) -
Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
by: Andrew D. Wiese, et al.
Published: (2019-04-01) -
CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VACCINATION OF CHILDREN AGAINST PNEUMOCOCCAL INFECTION IN THE AMUR REGION
by: A. G. Chuchalin, et al.
Published: (2016-06-01) -
Adult pneumococcal vaccination – new opportunities
by: ERNEST KUCHAR, et al.
Published: (2023-03-01) -
Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01)